Summary
Global Body Composition Analyzers Market to Reach $1.2 Billion by 2030
The global market for Body Composition Analyzers estimated at US$623.8 Million in the year 2022, is projected to reach a revised size of US$1.2 Billion by 2030, growing at a CAGR of 8.9% over the period 2022-2030. Bio-Impedance Analyzers, one of the segments analyzed in the report, is projected to record 10.2% CAGR and reach US$471.4 Million by the end of the analysis period. Growth in the Skinfold Calipers segment is estimated at 8.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $279.4 Million, While China is Forecast to Grow at 11% CAGR
The Body Composition Analyzers market in the U.S. is estimated at US$279.4 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$141.1 Million by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR.
Select Competitors (Total 87 Featured)
- GE Healthcare
- Hologic, Inc.
- iHealth Lab, Inc.
- Garmin Ltd.
- COSMED Srl
- Gima SpA
- Bodystat Limited
- Heal Force Bio-meditech Holdings Limited
- InBody Co., Ltd.
- Anker Technology (UK) Ltd.
- Etekcity Corporation
- Escali Corporation
- Greater Goods
- Diagnosis SA
- HMN Technologies Co., Ltd.
